MO Jan 2024 37.500 call
| Previous Close | 7.88 |
| Open | 7.88 |
| Bid | 7.75 |
| Ask | 8.05 |
| Strike | 37.50 |
| Expire Date | 2024-01-19 |
| Day's Range | 7.88 - 7.88 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 8.85k |
Simply Wall St.It Might Not Be A Great Idea To Buy Altria Group, Inc. (NYSE:MO) For Its Next Dividend
Altria Group, Inc. ( NYSE:MO ) is about to trade ex-dividend in the next four days. The ex-dividend date occurs one day...
Motley Fool2 Ridiculously Cheap Stocks You'll Regret Not Buying on the Dip
Blending value investing and income investing can be an effective strategy in the long run. This is because value investing (in theory) limits potential downside. Altria Group (NYSE: MO) and Williams-Sonoma (NYSE: WSM) are off their 52-week highs by 17% and 30%, respectively.
Motley Fool3 Stocks to Avoid This Week
Altria always seems to be on the losing side of settlements when its patrons suffer. Just last month, Altria reached a settlement in which it will pay $235 million to resolve at least 6,000 Juul-related cases.
Motley FoolAltria Stock: Buy, Sell, or Hold?
Altria (NYSE: MO) was once considered a stable dividend play for conservative investors. It's the largest tobacco company in America, it generates steady earnings growth, and it's raised its dividend every year since it spun off its overseas business as Philip Morris International (NYSE: PM) in 2008. Let's see why Altria woefully underperformed the market -- and if it's the right time to buy, sell, or hold its stock.
ZacksAltria (MO) Outpaces Stock Market Gains: What You Should Know
Altria (MO) closed the most recent trading day at $45.33, moving +1.68% from the previous trading session.
Motley FoolAltria Group Stock: Buy, Sell, or Hold?
Leading cigarette maker Altria Group (NYSE: MO) saw its net revenue drop 2.9% year over year in the first quarter of 2023, marking the fifth straight quarter of this happening. The stock has been a disaster for investors, down 19% over the past five years while the S&P 500 has climbed 50% during the same period. Does this mean it's time to sell Altria stock and move on?
ZacksAltria (MO) Lowers EPS View on Closing NJOY Holdings' Buyout
Altria (MO) acquires NJOY Holdings and accordingly updates its adjusted EPS guidance for the full-year 2023.
Business WireAltria Completes Acquisition of NJOY Holdings, Inc.; Updates 2023 Full-Year Earnings Guidance
RICHMOND, Va., June 01, 2023--ALTRIA COMPLETES ACQUISITION OF NJOY HOLDINGS, INC.; UPDATES 2023 FULL-YEAR EARNINGS GUIDANCE
ZacksWant Better Returns? Don't Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Business WireUpdate on Altria’s Pending Acquisition of NJOY Holdings, Inc.
RICHMOND, Va., May 26, 2023--Update on Altria’s Pending Acquisition of Njoy Holdings, Inc.
ZacksAltria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.
Motley Fool3 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying
These supercharged income stocks, with yields ranging from 7.2% to 13.6%, have been popular buys for some of Wall Street's brightest money managers.
Business WireAltria Holds 2023 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $0.94 Per Share
RICHMOND, Va., May 18, 2023--ALTRIA HOLDS 2023 ANNUAL MEETING OF SHAREHOLDERS; DECLARES REGULAR QUARTERLY DIVIDEND OF $0.94 PER SHARE
Motley FoolBetter Buy: Altria vs. Procter & Gamble
This pair of consumer staples companies sit at opposite ends of the yield spectrum, but investors should also consider their risk profiles.
- Reuters
RPT-UPDATE 2-FDA issues marketing denial for 6,500 flavored e-cigarettes
The U.S. Food and Drug Administration (FDA) on Friday issued marketing denial orders to 10 companies which collectively manufacture and market about 6,500 flavored e-liquid and e-cigarette products. The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action. Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA.
ReutersFDA issues marketing denial for 6,500 flavored e-cigarettes
The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action. Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA. The FDA named eight of these companies that received the denial orders, which include Imperial Vapors LLC, Savage Enterprises and Big Time Vapes, among others.
- Reuters
UPDATE 2-Altria agrees to $235 mln settlement to resolve Juul-related cases
Altria Group Inc said Wednesday that it will pay $235 million to settle at least 6,000 lawsuits accusing it of fueling a teen vaping epidemic through its former investment in e-cigarette maker Juul Labs Inc. It came shortly after San Francisco's public school district finished presenting its case against the company in a jury trial, which will now be cut short. Sarah London, one of the lead attorneys for plaintiffs in the litigation, in a statement said the deal would "provide extraordinary and truly meaningful relief for youth, parents, and governmental organizations nationwide."
ReutersAltria agrees to $235 million settlement to resolve Juul-related cases
(Reuters) -Altria Group Inc said Wednesday that it will pay $235 million to settle at least 6,000 lawsuits accusing it of fueling a teen vaping epidemic through its former investment in e-cigarette maker Juul Labs Inc. It came shortly after San Francisco's public school district finished presenting its case against the company in a jury trial, which will now be cut short. Sarah London, one of the lead attorneys for plaintiffs in the litigation, in a statement said the deal would "provide extraordinary and truly meaningful relief for youth, parents, and governmental organizations nationwide."
Business WireAltria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation
RICHMOND, Va., May 10, 2023--Altria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation
Motley FoolThis 5% High-Yield Stock Has More to Offer Investors
Like most tobacco companies, Philip Morris International (NYSE: PM) pays a hefty dividend. Investors should consider adding Philip Morris to their portfolio for the next 10 years. Philip Morris began as the cigarette company with non-U.S. rights to Marlboro when Altria spun it off about 15 years ago.
Motley FoolLooking for Outsized Dividend Income? Buy Altria Group Stock
Altria Group (NYSE: MO) has raised its annual payouts for 53 consecutive years, putting the tobacco giant among just 48 Dividend Kings -- companies that have raised their dividends annually for at least 50 years straight. Let's dig into why the company could be a buy for income-oriented investors. Led by its top-selling Marlboro cigarette brand and secondary brands like Parliament, Altria Group is the unquestioned leader of the U.S. combustible tobacco industry.
Business WireAltria to Host Webcast of 2023 Annual Meeting of Shareholders
RICHMOND, Va., May 04, 2023--Altria to host webcast of 2023 Annual Meeting of Shareholders.
ZacksAltria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Motley FoolShould You Buy the 5 Highest-Paying Dividend Stocks in the S&P 500?
Of the top five highest-yielding dividend stocks in the S&P 500, none have a yield of less than 7.4%. Here is some information about the five companies to help you decide if investing in them is right for you.
Motley FoolMy Biggest Red Flag About This Dividend King
Tobacco giant Altria Group (NYSE: MO) recently gave investors an updated look at the company when it held an investor event in late March. Company management laid out some goals for 2028, though shareholders might have left the event with some unanswered questions. Altria followed this up with its first-quarter earnings report about a month later.
